Hostname: page-component-68c7f8b79f-mk7jb Total loading time: 0 Render date: 2025-12-15T12:14:10.979Z Has data issue: false hasContentIssue false
  • English
  • Français

Direct cost savings associated with reduction in plasma metagenomic sequencing

Published online by Cambridge University Press:  21 October 2025

Caitlin Naureckas Li Open the ORCID record for Caitlin Naureckas Li [Opens in a new window] ,
Neil Jordan Open the ORCID record for Neil Jordan [Opens in a new window] ,
Shannon Haymond ,
David Koscinski Open the ORCID record for David Koscinski [Opens in a new window]  and
Ravi Jhaveri Open the ORCID record for Ravi Jhaveri [Opens in a new window]
Caitlin Naureckas Li*
Affiliation:
Northwestern University Feinberg School of Medicine, Chicago, IL, USA Division of Infectious Diseases, Ann and Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, USA
Neil Jordan
Affiliation:
Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Shannon Haymond
Affiliation:
Northwestern University Feinberg School of Medicine, Chicago, IL, USA Department of Pathology and Laboratory Medicine, Ann and Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, USA
David Koscinski
Affiliation:
Department of Information Management, Ann and Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, USA
Ravi Jhaveri
Affiliation:
Northwestern University Feinberg School of Medicine, Chicago, IL, USA Division of Infectious Diseases, Ann and Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, USA
*
Corresponding author: Caitlin Naureckas Li; Email: cli@luriechildrens.org
Get access Rights & Permissions [Opens in a new window]

Abstract

Following recognition that our hospital had higher use of plasma metagenomic next-generation sequencing than our peers, we implemented a process for approval by infectious diseases before test collection. This intervention is calculated to result in a direct cost savings of $79,505–$84,057/year, driven mainly by reduced laboratory costs.

Information

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , First View , pp. 1 - 3
Check for updates
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Niles, DT, Lee, RA, Lamb, GS, Dhaheri, FA, Boguniewicz, J. Plasma cell-free metagenomic next generation sequencing in the clinical setting for the diagnosis of infectious diseases: A systematic review and meta-analysis. Diagn Microbiol Infect Dis 2023;105:115838.10.1016/j.diagmicrobio.2022.115838CrossRefGoogle ScholarPubMed
Bergin, SP, Chemaly, RF, Dadwal, SS, et al. Plasma microbial cell-free DNA sequencing in immunocompromised patients with pneumonia: A prospective observational study. Clin Infect Dis Off Publ Infect Dis Soc Am 2024;78:775–784.10.1093/cid/ciad599CrossRefGoogle ScholarPubMed
Naureckas Li, C, Blumenthal, JA, Sick-Samuels, AC. Use and stewardship of molecular testing for diagnosis of infectious diseases: A cross-sectional survey. J Pediatr Infect Dis Soc 2025;14:piaf065. doi: 10.1093/jpids/piaf065.CrossRefGoogle ScholarPubMed
Provost, LP, Murray, SK. The Health Care Data Guide: Learning from Data for Improvement. 2nd ed. New Jersey, USA: John Wiley & Sons; 2022.Google Scholar
Norton, WE, Chambers, DA, Kramer, BS. Conceptualizing de-implementation in cancer care delivery. J Clin Oncol 2019;37:93–96.10.1200/JCO.18.00589CrossRefGoogle ScholarPubMed
Fowler, VG Jr, Durack, DT, Selton-Suty, C, et al. The 2023 Duke-International Society for Cardiovascular Infectious Diseases criteria for infective endocarditis: Updating the modified Duke criteria. Clin Infect Dis 2023;77:518–526.10.1093/cid/ciad271CrossRefGoogle ScholarPubMed
Blauwkamp, TA, Thair, S, Rosen, MJ, et al. Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease. Nat Microbiol 2019;4:663–674.10.1038/s41564-018-0349-6CrossRefGoogle ScholarPubMed
Fabre, V, Davis, A, Diekema, DJ, et al. Principles of diagnostic stewardship: A practical guide from the Society for Healthcare Epidemiology of America diagnostic stewardship task force. Infect Control Hosp Epidemiol 2023;44:178–185.10.1017/ice.2023.5CrossRefGoogle Scholar
Reece, R, Beckwith, CG. The infectious diseases specialist, at risk of extinction. J Infect Dis 2023;228:1649–1651.10.1093/infdis/jiad160CrossRefGoogle ScholarPubMed
Naureckas Li, C, Murtagh, K, Claussen, E, Malakooti, M, Jhaveri, R. Implementation and reimbursement of G0545 in infectious diseases billing at a freestanding pediatric hospital. J Pediatr Infect Dis Soc 2025;14:piaf061.10.1093/jpids/piaf061CrossRefGoogle Scholar
Supplementary material: File

Naureckas Li et al. supplementary material 1

Naureckas Li et al. supplementary material
Download Naureckas Li et al. supplementary material 1(File)
File 132.3 KB
Supplementary material: File

Naureckas Li et al. supplementary material 2

Naureckas Li et al. supplementary material
Download Naureckas Li et al. supplementary material 2(File)
File 30 KB